140410.KQ KOE
Mezzion Pharma Co.,Ltd.
1W: -17.3%
1M: +2.3%
3M: +10.4%
YTD: -55.2%
1Y: +84.5%
3Y: +61.7%
5Y: +51.0%
₩68,000.00 ($50.65)
-5600.00 (-7.61%)
Weekly Expected Move ±9.2%
₩55487
₩61743
₩68000
₩74257
₩80513
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩2.07T ($1.5B)
52W Range45850-179900
Volume156,305
Avg Volume131,419
Beta0.55
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODong-Hyun Park
Employees18
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2012-01-20
Websitemezzion.co.kr
570 Samseong-ro, Seokcheon Building, 7th Floor
Seoul, SL 6163
KR
Seoul, SL 6163
KR
+82 2 552 0113
About Mezzion Pharma Co.,Ltd.
Mezzion Pharma Co., Ltd. operates as a pharmaceutical enterprise focused on the discovery, production, and licensing of various medical treatments. The company's therapeutic offerings target conditions such as erectile dysfunction, benign prostatic hyperplasia, and Fontan disease. Established by Park, Dong-Hyun on September 25, 2002, its corporate base is located in Seoul, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found